The radiosynthesis and radiopharmacological evaluation including small animal PET imaging of a novel Positron emission tomography (PET) is a rapidly expanding noninvasive molecular imaging methodology which allows high sensitivity mapping of biochemical and physiological processes at the cellular and molecular level in vivo.
The PET radiometal copper-64 ( 64 Cu, t1/2 ¼ 12.7 h) has been the subject of intensive research eff orts for the development of both diagnostic PET radiotracers and radiotherapeutics. 10 MTUBo respectively. 64 Cu as a radiometal for molecular The application of imaging and radiotherapy requires the use of chelating agents to form kinetically inert and thermodynamically stable complexes. 15 High complex stability is needed to obviate hydrolysis and trans-chelation to copper chelating proteins like ceruloplasmin, superoxide dismutase (SOD), metallothioneins, and copper transporting ATPases. [16] [17] [18] stability. 22 Prominent examples are cryptands derived from sarcophagine (Sar) such as DiAmSar and SarAr (Fig. 1) and speci c activity. Using low concentrations of CryptTM resulted in only moderate radiochemical yields in the range of 51-64% and low speci c activities (entry 1 
22-24
Challenge experiments of [ 64 Cu]Cu-CryptTM with EDTA and NOTA gave higher rates of trans-chelation with EDTA for both [22] [23] [24] 6 .0, C 1 M sodium acetate pH 6.0, D de-ionized water, * 10 uL deionized water/ buff er/PBS was added at the end of the reaction as result of solvent evaporation during radiolabeling procedure at 37 C. murine blood samples provided data on distribution pattern of radioactivity in blood cells, plasma proteins, and plasma at diff erent time points (Fig. 3) . Results in Fig. 3 revealed low binding of radioactivity ( 15%) on blood cells at all investigated time points (5, 30, and 60 min). Increasing amounts of radio-activity were found in plasma protein fraction of murine blood which exceeded 70% of radioactivity in whole blood pool at 60 min. Consequently, radioactivity in plasma dropped over time, reaching 18% a er 60 min post injection (p.i. 
Conclusions
We have prepared and evaluated a novel 64 
